HIF1A and type 2 diabetes mellitus: Considering the significant role of HIF-1α in metabolic functions and the recent repositioning of PX478 for the treatment of type II diabetes, it is possible that consecutive dosing of PX478 over extended periods of time may lead to appetite suppression.